Wenbin Ying

1.1k total citations
25 papers, 879 citations indexed

About

Wenbin Ying is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Wenbin Ying has authored 25 papers receiving a total of 879 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Genetics and 6 papers in Immunology. Recurrent topics in Wenbin Ying's work include RNA Interference and Gene Delivery (9 papers), Virus-based gene therapy research (8 papers) and Toxin Mechanisms and Immunotoxins (6 papers). Wenbin Ying is often cited by papers focused on RNA Interference and Gene Delivery (9 papers), Virus-based gene therapy research (8 papers) and Toxin Mechanisms and Immunotoxins (6 papers). Wenbin Ying collaborates with scholars based in United States, China and United Kingdom. Wenbin Ying's co-authors include Andrew Baird, Barbara A. Sosnowski, David T. Curiel, Anne Hanneken, Nicholas Ling, Douglas A. Lappi, Buck E. Rogers, Glenn F. Pierce, C. Goldman and Julie A. Campain and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Cancer.

In The Last Decade

Wenbin Ying

25 papers receiving 824 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenbin Ying United States 16 624 394 226 92 89 25 879
Pauliina Lehtolainen Finland 13 655 1.0× 445 1.1× 232 1.0× 87 0.9× 52 0.6× 16 976
Anna Cascante Spain 18 696 1.1× 339 0.9× 170 0.8× 115 1.3× 33 0.4× 26 1.1k
Jason G. Fewell United States 18 704 1.1× 200 0.5× 129 0.6× 178 1.9× 44 0.5× 30 1.1k
Mattia Matasci Switzerland 18 602 1.0× 244 0.6× 218 1.0× 148 1.6× 72 0.8× 37 913
Ling Ma China 13 1.1k 1.7× 628 1.6× 269 1.2× 110 1.2× 50 0.6× 34 1.5k
Heike Lehrmann Austria 10 942 1.5× 306 0.8× 174 0.8× 90 1.0× 49 0.6× 10 1.1k
Adam M. Sonabend United States 13 531 0.9× 357 0.9× 348 1.5× 54 0.6× 18 0.2× 16 780
Xueqing Lun Canada 19 644 1.0× 431 1.1× 479 2.1× 313 3.4× 58 0.7× 26 1.3k
Siyuan Tan United States 10 1.7k 2.8× 510 1.3× 116 0.5× 51 0.6× 52 0.6× 22 2.0k
Weidan Peng United States 15 625 1.0× 229 0.6× 96 0.4× 169 1.8× 32 0.4× 28 938

Countries citing papers authored by Wenbin Ying

Since Specialization
Citations

This map shows the geographic impact of Wenbin Ying's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenbin Ying with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenbin Ying more than expected).

Fields of papers citing papers by Wenbin Ying

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenbin Ying. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenbin Ying. The network helps show where Wenbin Ying may publish in the future.

Co-authorship network of co-authors of Wenbin Ying

This figure shows the co-authorship network connecting the top 25 collaborators of Wenbin Ying. A scholar is included among the top collaborators of Wenbin Ying based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenbin Ying. Wenbin Ying is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Majeti, Bharat K., Zhihong O’Brien, Roger Adami, et al.. (2024). A Novel Lipid Nanoparticle NBF-006 Encapsulating Glutathione S-Transferase P siRNA for the Treatment of KRAS-Driven Non–small Cell Lung Cancer. Molecular Cancer Therapeutics. 24(1). 7–17. 3 indexed citations
2.
Liu, Yun, et al.. (2021). Anti-HSP47 siRNA lipid nanoparticle ND-L02-s0201 reverses interstitial pulmonary fibrosis in preclinical rat models. ERJ Open Research. 7(2). 733–2020. 29 indexed citations
3.
O’Brien, Zhihong, Bharat K. Majeti, Jean‐Pierre Clamme, et al.. (2018). Abstract 5917: A novel lipid nanoparticle (NBF-006) encapsulating glutathione S-transferase P (GSTP) siRNA for the treatment of KRAS-driven non-small cell lung cancer. Cancer Research. 78(13_Supplement). 5917–5917. 18 indexed citations
4.
Wang, Yuwei, Jihua Liu, Jun Zhang, et al.. (2014). A Cell-Based Pharmacokinetics Assay for Evaluating Tubulin-Binding Drugs. International Journal of Medical Sciences. 11(5). 479–487. 17 indexed citations
5.
Liu, Xiaoqing, Xinguo Jiang, Yun Liu, et al.. (2012). Effect of molecular weight of PGG–paclitaxel conjugates on in vitro and in vivo efficacy. Journal of Controlled Release. 161(1). 124–131. 40 indexed citations
6.
Bao, Yanjie, Yi Jin, Padmanabh Chivukula, et al.. (2012). Effect of PEGylation on Biodistribution and Gene Silencing of siRNA/Lipid Nanoparticle Complexes. Pharmaceutical Research. 30(2). 342–351. 87 indexed citations
7.
8.
Barrett, L B, Martin Berry, Wenbin Ying, et al.. (2004). CTb targeted non‐viral cDNA delivery enhances transgene expression in neurons. The Journal of Gene Medicine. 6(4). 429–438. 15 indexed citations
9.
Haisma, Hidde J., Herbert M. Pinedo, Barbara A. Sosnowski, et al.. (1999). Tumor-specific gene transfer via an adenoviral vector targeted to the pan-carcinoma antigen EpCAM. Gene Therapy. 6(8). 1469–1474. 95 indexed citations
10.
Printz, Marie A., Wenbin Ying, Diana K. Hoganson, et al.. (1999). Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: evidence for reduced toxicity and enhanced antitumor activity in mice.. PubMed. 59(11). 2608–14. 85 indexed citations
11.
Doukas, John A., Diana K. Hoganson, Michael Ong, et al.. (1999). Retargeted delivery of adenoviral vectors through fibroblast growth factor receptors involves unique cellular pathways. The FASEB Journal. 13(11). 1459–1466. 36 indexed citations
12.
Hoganson, Diana K., Lois A. Chandler, Wenbin Ying, et al.. (1998). Targeted Delivery of DNA Encoding Cytotoxic Proteins through High-Affinity Fibroblast Growth Factor Receptors. Human Gene Therapy. 9(17). 2565–2575. 24 indexed citations
13.
Hoganson, Diana K., Lois A. Chandler, Wenbin Ying, et al.. (1998). Targeted Delivery of DNA Encoding Cytotoxic Proteins through High-Affinity Fibroblast Growth Factor Receptors. Human Gene Therapy. 9(17). 2565–2575. 4 indexed citations
14.
Rogers, Buck E., Joanne T. Douglas, Barbara A. Sosnowski, et al.. (1998). Enhanced in vivo gene delivery to human ovarian cancer xenografts utilizing a tropism-modified adenovirus vector. 3(1). 25–31. 26 indexed citations
15.
Goldman, C., Buck E. Rogers, Barbara A. Sosnowski, et al.. (1997). Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptor.. PubMed. 57(8). 1447–51. 144 indexed citations
16.
17.
González-Castro, Ana María, Ann Logan, Wenbin Ying, et al.. (1994). Fibroblast growth factor in the hypothalamic-pituitary axis: differential expression of fibroblast growth factor-2 and a high affinity receptor.. Endocrinology. 134(5). 2289–2297. 51 indexed citations
18.
Ying, Wenbin, Darlene Martineau, Julie Beitz, Douglas A. Lappi, & Andrew Baird. (1994). Anti-B16-F10 melanoma activity of a basic fibroblast growth factor-saporin mitotoxin. Cancer. 74(3). 848–853. 15 indexed citations
19.
Lappi, Douglas A., Wenbin Ying, Isabel Barthelemy, et al.. (1994). Expression and activities of a recombinant basic fibroblast growth factor-saporin fusion protein.. Journal of Biological Chemistry. 269(17). 12552–12558. 46 indexed citations
20.
Hanneken, Anne, Wenbin Ying, Nicholas Ling, & Andrew Baird. (1994). Identification of soluble forms of the fibroblast growth factor receptor in blood.. Proceedings of the National Academy of Sciences. 91(19). 9170–9174. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pauliina Lehtolainen Breakdown of academic impact, for papers by Anna Cascante Breakdown of academic impact, for papers by Jason G. Fewell Breakdown of academic impact, for papers by Mattia Matasci Breakdown of academic impact, for papers by Ling Ma Breakdown of academic impact, for papers by Heike Lehrmann Breakdown of academic impact, for papers by Adam M. Sonabend Breakdown of academic impact, for papers by Xueqing Lun Breakdown of academic impact, for papers by Siyuan Tan Breakdown of academic impact, for papers by Weidan Peng
Rankless by CCL
2026